中药联合莫西沙星治疗老年性肺炎临床疗效观察  

Clinical Observation of Traditional Chinese Medicine Combined with Moxifloxacin in the Treatment of Senile Pneumonia

作　　者：刘凤[1] 谭利新 付世民 赵世鹏[1] 

机构地区：[1]山东省临朐县人民医院呼吸内科,临朐262600 [2]山东省临朐县人民医院影像科,临朐262600

出　　处：《中国医药导刊》2017年第5期492-493,共2页Chinese Journal of Medicinal Guide

摘　　要：目的:联合应用中药与莫西沙星对老年性肺炎患者进行治疗,探析并观察其临床疗效。方法:选择我院2016年1月~2017年1月期间收治的65例老年性肺炎患者作为研究对象,随机分为对照组和观察组,对照组患者利用莫西沙星进行治疗,观察组患者在对照组莫西沙星治疗的方式基础上给予中药加味补肺汤治疗,对比两组治疗效果与不良反应发生情况。结果:对照组患者总有效率为78.1%(25/32),观察组患者的总有效率为93.9%(31/33),结果显示,观察组患者的临床疗效显著优于对照组,差异显著(P<0.05),不良反应发生率比较,两组患者的差异不明显(P>0.05)。结论:中药联合莫西沙星治疗老年性肺炎临床疗效较好。Objective：Combined with traditional Chinese medicine and moxifloxacin for the treatment of patients with senile pneumonia,to explore and observe the clinical efficacy.Methods：65 patients with senile pneumonia who were treated in our hospitalwere selected as study subjects from January 2016 to January 2017,The patients in the control group were treated with moxifloxacin,the patients in the observation group were treated with moxifloxacin in the control group,and the treatment effect and adverse reaction were compared between the two groups Happening.Results：The total effective rate in the control group was 78.1% （25/32）,the total effective rate in the observation group was 93.9 % （31/33）.The results showed that the clinical efficacy of the observation group was significantly better than that of the control group,the difference was significant （P 〈 0.05）.There was no significant difference in the incidence of adverse reactions between the two groups （P 〉 0.05）.Conclusion：Chinese medicine combined with moxifloxacin in the treatment of senile pneumonia better clinical efficacy.

关 键 词：中药 莫西沙星 老年性肺炎 临床疗效 

分 类 号：R563.1[医药卫生—呼吸系统]